SENS earnings analysis
What we found in SENS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Senseonics Holdings, Inc. reported robust Q1 2026 results with revenues of $11.7 million, marking an 87% increase year-over-year and exceeding estimates by 18.7%. However, the company posted an EPS of -$0.71, which was below the expected -$0.69, highlighting continuing challenges in profitability despite strong sales growth.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong Revenue Growth
- Q1 2026 revenue soared to $11.7 million, an 87% increase from the previous year.
- Exceeded Revenue Estimates
- Revenue surpassed consensus estimates by 18.7%, beating the expected $9.87 million.
- Enhanced Full-Year Guidance
- The company raised its full-year revenue guidance to $60-64 million from a previous $58-62 million.
- Improved Market Performance
- The significant revenue increase reflects positive momentum in the U.S. market for the Eversense 365 product.
- Operational Expansion in Europe
- Management expects to transition Eversense operations in Europe successfully, with significant expected revenue opportunities.
- Increased Loan Capacity
- New amendments to the loan agreement with Hercules Capital now allow up to $140 million in borrowings.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Operating Losses Persist
- Despite revenue growth, the company reported an operating loss of -215.6% as a percentage of revenue.
- Increased Indebtedness Risk
- The amended loan agreement could lead to significant debt, raising vulnerability to economic shifts.
- Execution Risks in European Expansion
- Delays in the European Asset Purchases could disrupt operations and affect revenue generation in those markets.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.71
What they said about what is next.
Management has not provided explicit numeric EPS guidance but expects improved performance as operations normalize.
The filing reads better than the one before it.
What came before.
- 10-K · March 2, 2026
- Senseonics is transitioning commercial control of its Eversense CGM business back from Ascensia (U.S. asset purchase closed January 1, 2026) while ramping commercialization of the Eversense 365 (FDA approved September…
- 10-Q · August 6, 2025
- SENS reported Q2 revenue of $6,649,000 (7.92% beat vs consensus) and EPS of $(0.02) which matched estimates. Gross margin expanded to 46.9% but the company remains loss-making with an operating margin of -215.4% and…
- 10-Q · May 8, 2025
- Senseonics reported Q1 revenue of $6,257,000 (vs. estimate $5,570,000) and GAAP EPS of -$0.02, in line with consensus. Gross margin expanded to 24.1% year-over-year while operating losses remain substantial (operating…
- 10-Q · November 7, 2024
- Senseonics reported quarterly revenue of $4,263,000 (a beat vs. consensus $4,080,000) but reported a loss per share of $0.04. The 10‑Q discloses management's conclusion that recurring losses, anticipated debt repayments…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing SENS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever